Assignee
NEONC TECH INC
US·24 granted patents·26 pending applications·44 citations·filing 2014–2024
Top patents by PatentIndex Score
50 records- 0195US11970436B2Pharmaceutical compositions comprising monoterpenesNEONC TECH INC·Filed 2022·Granted Apr 30, 2024·1 cites·6 claims
- 0294US12208066B2Methods of permeabilizing the blood brain barrierNEONC TECH INC·Filed 2023·Granted Jan 28, 2025·1 cites·13 claims
- 0392US11077104B2Pharmaceutical compositions comprising POH derivativesNEONC TECH INC·Filed 2018·Granted Aug 3, 2021·3 cites·8 claims
- 0491US11013804B2Pharmaceutical compositions comprising POH derivativesNEONC TECH INC·Filed 2019·Granted May 25, 2021·3 cites·8 claims
- 0590US11147809B2Methods of treating neurofibromatosis with perillyl alcoholNEONC TECH INC·Filed 2017·Granted Oct 19, 2021·4 cites·28 claims
- 0689US9522918B2Pharmaceutical compositions comprising perillyl alcohol derivativesNEONC TECH INC·Filed 2016·Granted Dec 20, 2016·3 cites·15 claims
- 0789US9498448B2Pharmaceutical compositions comprising monoterpenesNEONC TECH INC·Filed 2015·Granted Nov 22, 2016·5 cites·9 claims
- 0889US9480659B2Pharmaceutical compositions comprising monoterpenesNEONC TECH INC·Filed 2015·Granted Nov 1, 2016·5 cites·15 claims
- 0989US2025066373A1Pharmaceutical compositions comprising perillyl alcohol derivativesNEONC TECH INC·Filed 2024·Application pending·0 cites
- 1088US9913838B2Methods of treating cancer using compositions comprising perillyl alcohol derivativeNEONC TECH INC·Filed 2014·Granted Mar 13, 2018·3 cites·7 claims
- 1186US10899691B2Pharmaceutical compositions comprising monoterpenesNEONC TECH INC·Filed 2019·Granted Jan 26, 2021·1 cites·7 claims
- 1286US10457618B2Pharmaceutical compositions comprising monoterpenesNEONC TECH INC·Filed 2016·Granted Oct 29, 2019·3 cites·11 claims
- 1385US10092562B2Pharmaceutical compositions comprising POH derivativesNEONC TECH INC·Filed 2017·Granted Oct 9, 2018·2 cites·8 claims
- 1484US10696680B2Pharmaceutical compositions comprising perillyl alcohol derivativesNEONC TECH INC·Filed 2018·Granted Jun 30, 2020·1 cites·9 claims
- 1582US9765081B2Pharmaceutical compositions comprising perillyl alcohol derivativesNEONC TECH INC·Filed 2017·Granted Sep 19, 2017·1 cites·4 claims
- 1682US2023043663A1Pharmaceutical compositions comprising perillyl alcohol derivativesNEONC TECH INC·Filed 2022·Application pending·0 cites
- 1782US2022133712A1Pharmaceutical compositions comprising poh derivativesNEONC TECH INC·Filed 2022·Application pending·0 cites
- 1881US9987237B2Methods and devices for using isoperillyl alcoholNEONC TECH INC·Filed 2015·Granted Jun 5, 2018·3 cites·9 claims
- 1981US9663428B2Pharmaceutical compositions comprising POH derivativesNEONC TECH INC·Filed 2014·Granted May 30, 2017·2 cites·7 claims
- 2081US9580372B2Pharmaceutical compositions comprising POH derivativesNEONC TECH INC·Filed 2014·Granted Feb 28, 2017·2 cites·4 claims
- 2179US2021283127A1Pharmaceutical compositions comprising poh derivativesNEONC TECH INC·Filed 2021·Application pending·0 cites
- 2279US2021130271A1Pharmaceutical compositions comprising monoterpenesNEONC TECH INC·Filed 2020·Application pending·0 cites
- 2378US9700524B2Pharmaceutical compositions comprising monoterpenesNEONC TECH INC·Filed 2016·Granted Jul 11, 2017·1 cites·12 claims
- 2475US2020230132A1Methods of treating cancer using compositions comprising perillyl alcohol derivativeNEONC TECH INC·Filed 2019·Application pending·0 cites
- 2574US12383621B2Pharmaceutical compositions comprising POH derivativesNEONC TECH INC·Filed 2021·Granted Aug 12, 2025·0 cites·5 claims
- 2674US11479554B2Pharmaceutical compositions comprising perillyl alcohol derivativesNEONC TECH INC·Filed 2020·Granted Oct 25, 2022·0 cites·6 claims
- 2773US2022096464A1Methods of treating cancer using compositions comprising perillyl alcohol derivativeNEONC TECH INC·Filed 2021·Application pending·0 cites
- 2872US2020170961A1Methods and devices for using isoperillyl alcoholNEONC TECH INC·Filed 2019·Application pending·0 cites
- 2971US2023145207A1Pharmaceutical compositions comprising poh derivatives and methods of useNEONC TECH INC·Filed 2023·Application pending·0 cites
- 3071US2020078355A1Pharmaceutical compositions comprising poh derivativesNEONC TECH INC·Filed 2019·Application pending·0 cites
- 3171US2021228498A1Methods of permeabilizing the blood brain barrierNEONC TECH INC·Filed 2019·Application pending·0 cites
- 3268US11559508B2Pharmaceutical compositions comprising POH derivatives and methods of useNEONC TECH INC·Filed 2018·Granted Jan 24, 2023·0 cites·3 claims
- 3368US2019054082A1Methods of treating cancer using compositions comprising perillyl alcohol derivativeNEONC TECH INC·Filed 2018·Application pending·0 cites
- 3466US9657026B2Pharmaceutical compositions comprising perillyl alcohol derivativesNEONC TECH INC·Filed 2016·Granted May 23, 2017·0 cites·4 claims
- 3566US2017369408A1Pharmaceutical compositions comprising poh derivativesNEONC TECH INC·Filed 2017·Application pending·0 cites
- 3665US2018155347A1Pharmaceutical compositions comprising perillyl alcohol derivativesNEONC TECH INC·Filed 2017·Application pending·0 cites
- 3765US2019367918A1Compositions and methods for delivering micrornaNEONC TECH INC·Filed 2019·Application pending·0 cites
- 3864US2017128578A1Pharmaceutical compositions comprising poh derivativesNEONC TECH INC·Filed 2016·Application pending·0 cites
- 3964US2017088494A1Pharmaceutical compositions comprising monoterpenesNEONC TECH INC·Filed 2016·Application pending·0 cites
- 4064US2019048346A1Compositions and methods for delivering micrornaNEONC TECH INC·Filed 2018·Application pending·0 cites
- 4163US10858305B2Perillyl alcohol-3-bromopyruvate conjugate and methods of treating cancerNEONC TECH INC·Filed 2017·Granted Dec 8, 2020·0 cites·10 claims
- 4260US2023212571A1Compositions and methods for delivering polynucleotidesNEONC TECH INC·Filed 2021·Application pending·0 cites
- 4359US2023405125A1Treatment of recurrent gioblastoma with perillyl alcoholNEONC TECH INC·Filed 2021·Application pending·0 cites
- 4458US2025186472A1Combination of poh and remdesivir for treatment of cns infectionsNEONC TECH INC·Filed 2021·Application pending·0 cites
- 4558US2024216293A1Use of perillyl alcohol to enhance levo-dopa deliveryNEONC TECH INC·Filed 2022·Application pending·0 cites
- 4657US2018280317A1Methods and devices for using isoperillyl alcoholNEONC TECH INC·Filed 2018·Application pending·0 cites
- 4754US9987271B2Method of treating nasopharyngeal carcinoma using perillyl alcohol derivativeNEONC TECH INC·Filed 2017·Granted Jun 5, 2018·0 cites·11 claims
- 4853US2021244820A1Pharmaceutical compositions comprising poh derivativesNEONC TECH INC·Filed 2019·Application pending·0 cites
- 4950US2022378780A1Pharmaceutical compositions comprising poh derivativesNEONC TECH INC·Filed 2020·Application pending·0 cites
- 5046US2017297985A1Methods of treating neurofibromatosis with perillyl alcoholNEONC TECH INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NEONC TECH INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →